The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
Hans Ludger TillmannMedizinische Klinik und Poliklinik II, Universität Leipzig, GermanyAbstract: Several options for the treatment of hepatitis B have been licensed in the last years: interferon, pegylated interferon, lamivudine, adefovir, entecavir, and telbivudine. In addition tenofovir h...
Saved in:
Main Author: | Hans Ludger Tillmann (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015) -
Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
by: Zhang C, et al.
Published: (2016) -
Th1 and Th2 Immune Response in Chronic Hepatitis B Patients during a Long-Term Treatment with Adefovir Dipivoxil
by: Yanfang Jiang, et al.
Published: (2010) -
How to compare antivirals in the treatment of chronic hepatitis B?
by: Leblebicioglu Hakan, et al.
Published: (2009) -
Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
by: Qian YY, et al.
Published: (2019)